E-LIB Suche - Ergebnisse für: Schettini, F

1

14P Assessing the predictive value of HER2DX pCR-score for ..:

Martínez-Sáez, O. ; Marin, M. ; Brunet, L. Pare...
ESMO Open. 9 (2024) - p. 103023 , 2024

Link: https://doi.org/10.1016/..

2

16P Determinants of response to short preoperative endocrin..:

Bravo, R. Gómez ; Walbaum, B. ; Schettini, F....
ESMO Open. 9 (2024) - p. 103024 , 2024

Link: https://doi.org/10.1016/..

3

12P Updated findings from the first prospective HER2DX clin..:

Martínez-Sáez, O. ; Marin, M. ; Hernández-Illán, E....
ESMO Open. 9 (2024) - p. 103021 , 2024

Link: https://doi.org/10.1016/..

4

22P Unveiling biological and prognostic differences among p..:

Walbaum, B. ; Chic, N. ; Bruñol, C. Crous...
ESMO Open. 9 (2024) - p. 103030 , 2024

Link: https://doi.org/10.1016/..

5

11P Influence of ctDNA variant allele frequency (VAF) on su..:

Fructuoso, I. Garcia ; Martínez-Sáez, O. ; Conte, B....
ESMO Open. 9 (2024) - p. 103020 , 2024

Link: https://doi.org/10.1016/..

6

8P Evaluating HER2DX pCR-Score and MRI response in predicti..:

Pascual, T. ; Martínez-Sáez, O. ; Brunet, L. Pare...
ESMO Open. 9 (2024) - p. 103017 , 2024

Link: https://doi.org/10.1016/..

7

163P Characterization of HER2-low breast cancer in young wo..:

Schettini, F. ; Blondeaux, E. ; Molinelli, C....
ESMO Open. 9 (2024) - p. 103185 , 2024

Link: https://doi.org/10.1016/..

8

136P Impact of ovarian stimulation on breast tumor biology:..:

El Gaoui, Y. Barral ; Manau, D. ; Chic, N....
ESMO Open. 9 (2024) - p. 103123 , 2024

Link: https://doi.org/10.1016/..

9

P317 A…TELL–TALE HEART:

Fischetti, S ; Brunelli, V ; Schettini, F...
European Heart Journal Supplements. 25 (2023) Supplement_D - p. D166-D167 , 2023

Link: https://doi.org/10.1093/..

10

MT52 Economic and Organizational Advantages of Mrgfus for t..:

Ferrario, L.B. ; Garagiola, E. ; Asperti, F....
Value in Health. 26 (2023) 12 - p. S436 , 2023

Link: https://doi.org/10.1016/..

11

RWD101 Intravitreal Therapies and Their Patterns of Use in ..:

Foglia, E. ; Garagiola, E. ; Bellavia, D....
Value in Health. 26 (2023) 12 - p. S523 , 2023

Link: https://doi.org/10.1016/..

12

10P HER2 loss and PAM50 dynamics after neoadjuvant therapy ..:

Morganti, S. ; Brasó-Maristany, F. ; Rey, M....
ESMO Open. 8 (2023) 1 - p. 101234 , 2023

Link: https://doi.org/10.1016/..

13

Prognostic value of HER2-low status in breast cancer: a sys..:

Molinelli, C. ; Jacobs, F. ; Agostinetto, E....
ESMO Open. 8 (2023) 4 - p. 101592 , 2023

Link: https://doi.org/10.1016/..

14

208P Clinical characteristics and prognostic factors in pat..:

Laakmann, E. ; Agostinetto, E. ; van Ramshorst, M....
ESMO Open. 8 (2023) 1 - p. 101397 , 2023

Link: https://doi.org/10.1016/..

15

8P First decision impact study of HER2DX in patients (pts) ..:

Saez, O. Martinez ; Brasó-Maristany, F. ; Marín-Aguilera, M....
ESMO Open. 8 (2023) 1 - p. 101232 , 2023

Link: https://doi.org/10.1016/..